Management of Nonalcoholic Steatohepatitis
Authors:
- 1 August 2012
- journal article
- research article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 16 (3) , 631-645
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysisJournal of Hepatology, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- A position statement on NAFLD/NASH based on the EASL 2009 special conferenceJournal of Hepatology, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic SteatohepatitisHepatology, 2009
- Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and CarbohydratesNew England Journal of Medicine, 2009
- Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feedingAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat DietNew England Journal of Medicine, 2008
- Fructose consumption as a risk factor for non-alcoholic fatty liver diseaseJournal of Hepatology, 2008
- Thiazolidinedione Use and Bone Loss in Older Diabetic AdultsThe Journal of Clinical Endocrinology & Metabolism, 2006